Supplementary Figure S1 from Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers

Abstract

Supplementary Figure S1. Protein-inhibitor complexes assessed by molecular dynamics studies.